The global kinesin like protein KIF11 market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Kinesins are found in all eukaryotic organisms. They are essential to all eukaryotic cells that are involved in diverse cellular functions such as microtubule dynamics and morphogenesis, chromosome segregation, spindle formation and elongation and transport of organelles. The major factor contributing to the growth of the global kinesin like protein KIF11 market is the increasing prevalence of cancer across the globe. 

According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. In men, prostate, lung, and colorectal cancers will account for an estimated 43% of all cancers diagnosed while for women, the three most common cancers are breast, lung, and colorectal which will account for an estimated 50% of all new cancer diagnoses in women in 2020. Furthermore, there were 18.1 million new cases and 9.5 million cancer-related mortalities globally in 2018 which is anticipated to rise to 29.5 million and the number of cancer-related mortalities to 16.4 million by 2040. In the case of cancer, KIF11 inhibitors are being developed for targeting the active KIF11 proteins during abnormal cell division. Hence, the rising prevalence of cancer is increasing is driving the growth of the market.

Moreover, KIFs converts chemical energy into mechanical force by hydrolysis of adenosine triphosphate (ATP). They are motor proteins that act upon microtubules to move vesicles and organelles from the cell centre to the periphery. Additionally, it causes the beating of flagella and cilia. Furthermore, some major players in the market include Merck & Co., Inc., Novartis International AG, and Pfizer Inc., among others. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape- Merck & Co., Inc., Novartis International AG, and Pfizer Inc., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Kinesin Like Protein KIF11 Market Report by Segment

By Type 

    • 4SC-205

    • ALN-VSP

    • BIND-267

    • BQS-481

    • Others

By Application 

    • Colorectal Cancer

    • Breast Cancer

    • Kidney Cancer

    • Liver Cancer

    • Others

Global Kinesin Like Protein KIF11 Market Report by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa